BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Acetaminophen
,
rs3825942
,
VEGFA
,
Apoptosis
,
Ischemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ATXN2;jsessionid=DB49C2EF57F3E3D38E69DA0906EA9594
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole brain
Smooth muscle
Cingulate cortex
Prefrontal cortex
Adrenal gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
ATXN2 is a target of N-terminal proteolysis.
Abnormal open states patterns in the ATXN2 DNA sequence depends on the CAG repeats length.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for ATXN2;jsessionid=DB49C2EF57F3E3D38E69DA0906EA9594
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ